Arcadia Biosciences, Inc. (RKDA) Insider Trading Activity

NASDAQ$2.4
Market Cap
$3.28M
Sector
Basic Materials
Industry
Agricultural Inputs
Rank in Sector
65 of 152
Rank in Industry
6 of 13

RKDA Insider Trading Activity

RKDA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$3,486
2
100
Sells
$0
0
0

Related Transactions

Kawakami MarkChief Financial Officer
1
$1,743
0
$0
$1,743
Schaefer Thomas J.Chief Executive Officer
1
$1,743
0
$0
$1,743

About Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.

Insider Activity of Arcadia Biosciences, Inc.

Over the last 12 months, insiders at Arcadia Biosciences, Inc. have bought $3,486 and sold $0 worth of Arcadia Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Arcadia Biosciences, Inc. have bought $8,099 and sold $0 worth of stock each year.

Highest buying activity among insiders over the last 12 months: Kawakami Mark (Chief Financial Officer) — $1,743. Schaefer Thomas J. (Chief Executive Officer) — $1,743.

The last purchase of 700 shares for transaction amount of $1,743 was made by Schaefer Thomas J. (Chief Executive Officer) on 2025‑02‑03.

List of Insider Buy and Sell Transactions, Arcadia Biosciences, Inc.

2025-02-03PurchaseSchaefer Thomas J.Chief Executive Officer
700
0.0264%
$2.49
$1,743
-24.70%
2025-02-03PurchaseKawakami MarkChief Financial Officer
700
0.0264%
$2.49
$1,743
-24.70%
2024-08-01PurchaseSchaefer Thomas J.Chief Executive Officer
700
0.0361%
$2.06
$1,442
+33.96%
2024-08-01PurchaseKawakami MarkChief Financial Officer
700
0.0361%
$2.06
$1,442
+33.96%
2024-02-01PurchaseSchaefer Thomas J.Chief Financial Officer
700
0.053%
$2.06
$1,442
+18.80%
2023-08-04PurchaseSchaefer Thomas J.Chief Financial Officer
649
0.0538%
$3.67
$2,382
-36.70%
2023-05-30PurchaseJacot Stanley JrChief Executive Officer
5,000
0.5634%
$4.31
$21,550
-31.17%
2023-02-01PurchaseSchaefer Thomas J.Chief Financial Officer
700
0.0017%
$0.23
$161
-62.22%
2022-08-01PurchaseHaley PamelaChief Financial Officer
700
0.0024%
$0.70
$490
-65.86%
2020-08-03PurchasePlavan Matthew TChief Executive Officer
585
0.0001%
$3.16
$1,849
-21.37%
2020-08-03PurchaseShultz RandallChief Technology Officer
700
0.0001%
$3.16
$2,212
-21.37%
2020-08-03PurchaseHaley PamelaChief Financial Officer
700
0.0001%
$3.16
$2,212
-21.37%
2020-02-03PurchasePlavan Matthew TChief Executive Officer
700
<0.0001%
$1.72
$1,204
-32.93%
2020-02-03PurchaseReiter SarahChief Commercial Officer
700
<0.0001%
$1.72
$1,204
-32.93%
2020-02-03PurchaseHaley PamelaChief Financial Officer
700
<0.0001%
$1.72
$1,204
-32.93%
2019-12-23PurchaseReiter SarahChief Commercial Officer
900
0.0003%
$5.95
$5,355
-38.71%
2019-11-19PurchaseReiter SarahChief Commercial Officer
1,000
0.0003%
$4.52
$4,520
-16.96%
2019-11-18PurchaseMurray Lilian Shackelforddirector
5,000
0.0014%
$4.25
$21,250
-11.27%
2019-11-14PurchasePlavan Matthew TChief Executive Officer
1,000
0.0003%
$4.08
$4,080
-7.58%
2019-09-23PurchasePlavan Matthew TChief Executive Officer
2,000
0.0007%
$5.25
$10,500
-23.18%
Total: 79
*Gray background shows transactions not older than one year

Insider Historical Profitability

<0.0001%
Schaefer Thomas J.Chief Executive Officer
2819
0.2063%
$6,765.6050
<0.0001%
Kawakami MarkChief Financial Officer
2681
0.1962%
$6,434.4020
+33.96%
Mandala Agribusiness Co-Investments I Ltd10 percent owner
9080808
664.6038%
$21.79M10
BISHOP TERRI C10 percent owner
1160714
84.95%
$2.79M10
Shupp Darby E
1160714
84.95%
$2.79M10
Garg Uday
375000
27.4454%
$900,000.0010
Knauf Vic C.Chief Scientific Officer
47134
3.4496%
$113,121.60011
Comcowich Kevindirector
20000
1.4638%
$48,000.0020
<0.0001%
Emlay DonVP Regulatory and Compliance
17729
1.2975%
$42,549.6003
Plavan Matthew TChief Executive Officer
14285
1.0455%
$34,284.0080
<0.0001%
Shultz RandallChief Technology Officer
13000
0.9514%
$31,200.0010
<0.0001%
Reis James Richarddirector
12500
0.9148%
$30,000.0010
Salameh RogerChief Operating Officer
11415
0.8354%
$27,396.0005
Murray Lilian Shackelforddirector
8524
0.6239%
$20,457.6010
<0.0001%
Rey Eric J.director
7335
0.5368%
$17,604.00118
Haley PamelaChief Financial Officer
5088
0.3724%
$12,211.2030
<0.0001%
Jacot Stanley JrChief Executive Officer
5000
0.3659%
$12,000.0010
<0.0001%
Reiter SarahChief Commercial Officer
3800
0.2781%
$9,120.0040
<0.0001%
Brandwein Steven F.Interim Chief Financ. Officer
750
0.0549%
$1,800.0003
Lu ZhongjinVP Product Development
558
0.0408%
$1,339.2006
*Gray background shows insiders who have made transactions during last year

Historical Insider Profitability vs. Competitors

$33,907,333
80
-6.48%
$447.25M
$13,808,268
64
13.34%
$14.05B
$8,947,986
56
15.63%
$8.37B
$6,478,706
48
-2.03%
$122.4M
$22,438,780
36
44.29%
$1.2B
$15,104,413
29
22.21%
$47.06B
Arcadia Biosciences, Inc.
(RKDA)
$301,868
25
-25.76%
$3.28M
$7,539,965
19
3.31%
$1.92B
$2,228,403
2
-22.01%
$3.69B
$2,268,015
2
-4.09%
$10.36M

RKDA Institutional Investors: Active Positions

Increased Positions5+27.78%10,601+17.9%
Decreased Positions6-33.33%4,361-7.36%
New Positions3New10,393New
Sold Out Positions<1Sold Out272Sold Out
Total Postitions17-5.56%65,469+10.54%

RKDA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$30.001.4%14,03800%2025-09-30
Geode Capital Management, Llc$28.001.3%13,001+206+1.61%2025-09-30
Mariner, Llc$26.001.23%12,264-2,236-15.42%2025-09-30
State Street Corp$26.001.22%12,14600%2025-09-30
Drw Securities, Llc$22.001%10,032+10,032New2025-09-30
Tower Research Capital Llc (Trc)$4.000.17%1,687-228-11.91%2025-09-30
Ubs Group Ag$2.000.11%1,099-1,445-56.8%2025-09-30
Morgan Stanley$1.000.06%608-179-22.75%2025-09-30
Citigroup Inc$1.000.04%356+356New2025-09-30
Sbi Securities Co., Ltd.$00.01%122+2+1.67%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.